Do You Believe in the Upside Potential of Zimmer Biomet Holdings (ZBH)?

Group 1: Ariel Global Fund Performance - Ariel Global Fund reported a +7.38% return in Q2 2025, underperforming the MSCI ACWI Index which returned +11.53% and the MSCI ACWI Value Index which returned +5.84% [1] - The quarter experienced significant volatility, with stocks initially falling after the "Liberation Day" tariff announcement in early April, followed by a rebound due to a pause in tariff implementation and enthusiasm for AI-themed stocks [1] Group 2: Zimmer Biomet Holdings, Inc. Overview - Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is a leading medical technology company with a market capitalization of $19.635 billion, closing at $99.12 per share on September 16, 2025 [2] - The company reported net sales of $2.077 billion in Q2 2025, reflecting a 7% increase on a reported basis [4] Group 3: Investment Outlook for Zimmer Biomet Holdings, Inc. - Ariel Global Fund added Zimmer Biomet Holdings, Inc. to its portfolio, anticipating mid single-digit top-line growth over the next three to five years due to new product launches [3] - Despite the potential of Zimmer Biomet, the fund noted that certain AI stocks may offer greater upside potential and less downside risk [4]